D. Schrijvers

7.0k citations
133 papers · 5.4k · h-index 39

Impact in

  • Immunology top 1%
    • Atherosclerosis and Cardiovascular Diseases
    • Phagocytosis and Immune Regulation
    • Immune cells in cancer
  • Otorhinolaryngology top 2%
    • Head and Neck Cancer Studies

Papers in

  • Immunology 32
    • Phagocytosis and Immune Regulation 15
    • Atherosclerosis and Cardiovascular Diseases 8
    • Immune cells in cancer 7
  • Molecular Biology 31
    • Cell death mechanisms and regulation 9
Co-authors
Wim Martinet (45 shared papers)Guido R.Y. De Meyer (48 shared papers)Arnold G. Herman (12 shared papers)Mark Kockx (10 shared papers)Mandy O. J. Grootaert (6 shared papers)George Kuriakose (2 shared papers)Ira Tabas (2 shared papers)Hidde Bult (15 shared papers)
Journals
Annals of Oncology (19 papers)Arteriosclerosis Thrombosis and Vascular Biology (6 papers)Basic Research in Cardiology (4 papers)European Journal of Cancer (4 papers)PLoS ONE (4 papers)
Partner nations
BelgiumNetherlandsGermany

In The Last Decade

D. Schrijvers

129 papers receiving 5.3k citations

Peers

D. Schrijvers
Comparison fields: 5 of 134
  • Immunology 1.7k
  • Otorhinolaryngology 224
  • Epidemiology 1.2k
  • Cancer Research 494
  • Oncology 860
Replace Emile de Heer with:
Emile de Heer Netherlands
Timo Paavonen Finland
Piotr Dzięgiel Poland
David M. Harlan United States
Carlo Vancheri Italy
H. Peter Rodemann Germany
Xi Kathy Zhou United States
Edward R. Sauter United States
Naoyuki Kamatani Japan
Poupak Fallahi Italy
D. Schrijvers relative to Emile de Heer Netherlands Emile de Heer's profile →
Citations per field
00.5×2×3×4.3×
Emile de Heer · 1×
Citations per year

Countries citing papers authored by D. Schrijvers

Since Specialization
Citations

This map shows the geographic impact of D. Schrijvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Schrijvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Schrijvers more than expected).

Fields of papers citing papers by D. Schrijvers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Schrijvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Schrijvers. The network helps show where D. Schrijvers may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Schrijvers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Schrijvers Line = papers co-authored together D. Schrijvers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis
Arteriosclerosis Thrombosis and Vascular Biology ·D. Schrijvers, Guido R.Y. De Meyer, Mark Kockx, Arnold G. Herman, Wim Martinet
2005407
2
Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe −/− Mice
Arteriosclerosis Thrombosis and Vascular Biology ·Edward B. Thorp, Dongying Cui, D. Schrijvers, George Kuriakose, Ira Tabas
2008284
3
Autophagy in Vascular Disease
Circulation Research ·Guido R.Y. De Meyer, Mandy O. J. Grootaert, Cédéric F. Michiels, Ammar Kurdi, D. Schrijvers, Wim Martinet
2015237
4
Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis
Autophagy ·Mandy O. J. Grootaert, Paula A. da Costa Martins, Nicole Bitsch, Isabel Pintelon, Guido R.Y. De Meyer, Wim Martinet, D. Schrijvers
2015233
5
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability
Cardiovascular Research ·D. Schrijvers, Guido R.Y. De Meyer, A HERMAN, Wim Martinet
2006217
6
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Annals of Oncology ·Matti Aapro, Yves Béguin, Carsten Bokemeyer, Mario Dicato, Pere Gascón, John A. Glaspy, Axel Hofmann, Hartmut Link, T. Littlewood, Heinz Ludwig, Anders Österborg, P. Pronzato, Valeria Santini, D. Schrijvers, R. Stauder, Kim Jordan, Jørn Herrstedt
2017173
7
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
British Journal of Cancer ·J. Pelgrims, Filip De Vos, Jan Van den Brande, D. Schrijvers, A. Prové, Jan B. Vermorken
2000169
8
Autophagy in Atherosclerosis
Arteriosclerosis Thrombosis and Vascular Biology ·D. Schrijvers, Guido R.Y. De Meyer, Wim Martinet
2011169
9
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Pharmacology & Therapeutics ·Rachid Ammi, Jorrit De Waele, Yannick Willemen, Ilse Van Brussel, D. Schrijvers, Eva Lion, Evelien Smits
2014140
10
Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death
European Heart Journal ·Carole Van der Donckt, Jozef L. Van Herck, D. Schrijvers, Greetje Vanhoutte, Marleen Verhoye, Ines Blockx, Annemie Van der Linden, Dries Bauters, Henri Roger Lijnen, Judith C. Sluimer, Lynn Roth, Cor E. Van Hove, Paul Fransen, Michiel Knaapen, Anne-Sophie Hervent, Gilles W. De Keulenaer, Hidde Bult, Wim Martinet, Arnold G. Herman, Guido R.Y. De Meyer
2014134
11
Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice
Journal of Clinical Investigation ·Tracie A. Seimon, Yibin Wang, Seongah Han, Takafumi Senokuchi, D. Schrijvers, George Kuriakose, Alan R. Tall, Ira Tabas
2009131
12
Coping with toxicities of docetaxel (TaxotereTM)
Annals of Oncology ·D. Schrijvers, J. Wanders, Luc Dirix, A. Prové, I. Vonck, A. van Oosterom, S.B. Kaye
1993123
13
Defective Autophagy in Atherosclerosis: To Die or to Senesce?
Oxidative Medicine and Cellular Longevity ·Mandy O. J. Grootaert, Lynn Roth, D. Schrijvers, Guido R.Y. De Meyer, Wim Martinet
2018120
14
Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: A step closer to the unraveling of neuroglobin and cytoglobin functions
Gene ·Elke Fordel, Liesbet Thijs, Wim Martinet, D. Schrijvers, Luc Moëns, Sylvia Dewilde
2007107
15
Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
Annals of Oncology ·D. Schrijvers, Hadewijch De Samblanx, Fausto Roila
2010104
16
7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle Cells
Arteriosclerosis Thrombosis and Vascular Biology ·Wim Martinet, M. De Bie, D. Schrijvers, Guido R.Y. De Meyer, Arnold G. Herman, Mark Kockx
2004104
17
Necrotic cell death in atherosclerosis
Basic Research in Cardiology ·Wim Martinet, D. Schrijvers, Guido R.Y. De Meyer
2011100
18
Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck
Annals of Oncology ·Patrick Schöffski, G. Catimel, A.S.T. Planting, Droz Jp, Jaap Verweij, D. Schrijvers, L. Gras, A. H. G. J. Schrijvers, J. Wanders, A.-R. Hanauske
199983
19
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
Autoimmunity Reviews ·Ilse Van Brussel, Wai Ping Lee, Miche Rombouts, Amber H. Nuyts, Marthe Heylen, Benedicte Y. De Winter, Nathalie Cools, D. Schrijvers
201373
20
European Society for Medical Oncology (ESMO) Program for the Integration of Oncology and Palliative Care: a 5-year review of the Designated Centers’ incentive program
Annals of Oncology ·Nathan I. Cherny, Raphael Catane, D. Schrijvers, M. Kloke, Florian Strasser
200971

About D. Schrijvers

D. Schrijvers is a scholar working on Immunology, Molecular Biology, Epidemiology, Oncology and Pulmonary and Respiratory Medicine, having authored 133 papers that have together received 5.4k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (15 papers), Autophagy in Disease and Therapy (12 papers), Cell death mechanisms and regulation (9 papers), Cancer Treatment and Pharmacology (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Immune cells in cancer (7 papers), Nitric Oxide and Endothelin Effects (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). The work is most often cited by research in Immunology (1.7k citations), Otorhinolaryngology (224 citations), Epidemiology (1.2k citations), Cancer Research (494 citations) and Oncology (860 citations). D. Schrijvers has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Wim Martinet, Guido R.Y. De Meyer, Arnold G. Herman, Mark Kockx, Mandy O. J. Grootaert, George Kuriakose, Ira Tabas, Hidde Bult, Edward B. Thorp and Dongying Cui. Their work appears in journals such as Annals of Oncology, Arteriosclerosis Thrombosis and Vascular Biology, Basic Research in Cardiology, European Journal of Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emile de HeerBreakdown of academic impact, for papers by Timo PaavonenBreakdown of academic impact, for papers by Piotr DzięgielBreakdown of academic impact, for papers by David M. HarlanBreakdown of academic impact, for papers by Carlo VancheriBreakdown of academic impact, for papers by H. Peter RodemannBreakdown of academic impact, for papers by Xi Kathy ZhouBreakdown of academic impact, for papers by Edward R. SauterBreakdown of academic impact, for papers by Naoyuki KamataniBreakdown of academic impact, for papers by Poupak Fallahi